
    
      1. This study was done over a period of one and a half years from July 2015 to December
           2016. A total of 229 patients who presented with acute middle cerebral artery stroke and
           admitted at Post graduate institute of medical education and research were evaluated for
           recruitment into this study.

        2. Participants who satisfied the inclusion criteria were randomized at 1 week into control
           and stem cell infusion test group within 15 days of stroke onset.

        3. Investigators evaluated 20 patients, with 10 each in control and stem cell infusion test
           group.

        4. Participants in the test group were infused autologous bone marrow mononuclear cells
           through intraarterial route using a microcatheter which was placed in proximal
           ipsilateral M1 segment of MCA. Participants in the control group did not receive stem
           cell therapy. Rest of the pharmacological treatment and physiotherapy were similar in
           both groups for the period of 6 months.

      5,Participants were evaluated with clinical and radiological follow up at 6 months.
    
  